Weight Loss Drugs Are Poised to Cost New York City Retail, According to Study
Briefly

The slimming down of America will have an enormous impact on retailers and could cost them approximately $20 million each year due to incorrect size curves. These losses will only accelerate as more people take GLP-1 drugs for weight loss.
Sales of women's button-down shirts in smaller sizes have increased by 12 percent, while sales of larger sizes decreased by almost 11 percent, indicating a shift in the size curve due to weight loss drugs.
Read at WWD
[
|
]